Kenvue Inc. (NYSE:KVUE) Given Average Recommendation of "Hold" by Brokerages

Key Points

• Kenvue Inc. has received an average recommendation of "Hold" from analysts, with one sell, seven hold, and five buy ratings from thirteen analysts covering the firm.
• The company's earnings report indicated $0.29 earnings per share, slightly surpassing analysts' expectations, alongside revenue of $3.84 billion for the quarter.
• Kenvue recently declared a quarterly dividend of $0.2075 per share, representing an annualized dividend of $0.83 with a yield of 4.0%.

Kenvue Inc. (NYSE:KVUE - Get Free Report) has been assigned a consensus recommendation of "Hold" from the thirteen ratings firms that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and five have issued a buy recommendation on the company. The average 1 year target price among analysts that have covered the stock in the last year is $24.3750.

A number of equities research analysts recently commented on KVUE shares. UBS Group dropped their price objective on Kenvue from $25.00 to $23.00 and set a "neutral" rating for the company in a report on Thursday, July 17th. Barclays dropped their price objective on Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Tuesday, July 15th. JPMorgan Chase & Co. dropped their price objective on Kenvue from $27.00 to $26.00 and set an "overweight" rating for the company in a report on Friday, July 25th. Royal Bank Of Canada dropped their price objective on Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a report on Friday, August 8th. Finally, Bank of America dropped their price objective on Kenvue from $27.00 to $25.00 and set a "buy" rating for the company in a report on Tuesday, July 15th.

Kenvue Trading Down 0.5%

Shares of KVUE stock traded down $0.10 on Monday, reaching $20.36. 7,183,827 shares of the stock were exchanged, compared to its average volume of 17,182,041. The stock has a market cap of $39.06 billion, a PE ratio of 27.51, a P/E/G ratio of 2.97 and a beta of 0.83. Kenvue has a one year low of $19.75 and a one year high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. The stock has a 50 day moving average price of $21.42 and a 200 day moving average price of $22.42.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping analysts' consensus estimates of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The firm's quarterly revenue was down 4.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities research analysts forecast that Kenvue will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were issued a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 4.1%. This is an increase from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date was Wednesday, August 13th. Kenvue's dividend payout ratio is currently 112.16%.

Institutional Investors Weigh In On Kenvue

Several large investors have recently modified their holdings of KVUE. Evergreen Wealth Solutions LLC grew its holdings in shares of Kenvue by 2.6% during the first quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company's stock worth $402,000 after buying an additional 432 shares in the last quarter. Fulton Bank N.A. grew its holdings in shares of Kenvue by 0.6% during the first quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock worth $1,892,000 after buying an additional 465 shares in the last quarter. Scott & Selber Inc. grew its holdings in shares of Kenvue by 0.4% during the first quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock worth $2,557,000 after buying an additional 475 shares in the last quarter. AlphaCore Capital LLC grew its holdings in shares of Kenvue by 9.9% during the second quarter. AlphaCore Capital LLC now owns 5,287 shares of the company's stock worth $111,000 after buying an additional 476 shares in the last quarter. Finally, Wealth Alliance LLC grew its holdings in shares of Kenvue by 1.6% during the first quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock worth $762,000 after buying an additional 486 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.